Your browser doesn't support javascript.
loading
Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases.
Rodríguez-Hernández, Guillermo; Hauer, Julia; Martín-Lorenzo, Alberto; Schäfer, Daniel; Bartenhagen, Christoph; García-Ramírez, Idoia; Auer, Franziska; González-Herrero, Inés; Ruiz-Roca, Lucia; Gombert, Michael; Okpanyi, Vera; Fischer, Ute; Chen, Cai; Dugas, Martin; Bhatia, Sanil; Linka, René Martin; Garcia-Suquia, Marta; Rascón-Trincado, María Victoria; Garcia-Sanchez, Angel; Blanco, Oscar; García-Cenador, Maria Begoña; García-Criado, Francisco Javier; Cobaleda, César; Alonso-López, Diego; De Las Rivas, Javier; Müschen, Markus; Vicente-Dueñas, Carolina; Sánchez-García, Isidro; Borkhardt, Arndt.
Affiliation
  • Rodríguez-Hernández G; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus M. de Unamuno s/n, Salamanca, Spain.
  • Hauer J; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Martín-Lorenzo A; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
  • Schäfer D; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus M. de Unamuno s/n, Salamanca, Spain.
  • Bartenhagen C; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • García-Ramírez I; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
  • Auer F; Department of Computer Science, Bonn-Rhein-Sieg University of Applied Sciences, Sankt Augustin, Germany.
  • González-Herrero I; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus M. de Unamuno s/n, Salamanca, Spain.
  • Ruiz-Roca L; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Gombert M; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
  • Okpanyi V; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus M. de Unamuno s/n, Salamanca, Spain.
  • Fischer U; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Chen C; Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Campus M. de Unamuno s/n, Salamanca, Spain.
  • Dugas M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Bhatia S; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
  • Linka RM; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
  • Garcia-Suquia M; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
  • Rascón-Trincado MV; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
  • Garcia-Sanchez A; Department of Computer Science, Bonn-Rhein-Sieg University of Applied Sciences, Sankt Augustin, Germany.
  • Blanco O; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
  • García-Cenador MB; Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Medical Faculty, Düsseldorf, Germany.
  • García-Criado FJ; Departamento de Ciencias Biomédicas y del Diagnóstico, Área de Obstetricia y Ginecología, HUS-Universidad de Salamanca, Salamanca, Spain.
  • Cobaleda C; Departamento de Ciencias Biomédicas y del Diagnóstico, Área de Obstetricia y Ginecología, HUS-Universidad de Salamanca, Salamanca, Spain.
  • Alonso-López D; Departamento de Ciencias Biomédicas y del Diagnóstico, Área de Obstetricia y Ginecología, HUS-Universidad de Salamanca, Salamanca, Spain.
  • De Las Rivas J; IBSAL, Facultad de Medicina, Universidad de Salamanca, Salamanca, Spain.
  • Müschen M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Vicente-Dueñas C; Departamento de Anatomía Patológica, Universidad de Salamanca, Salamanca, Spain.
  • Sánchez-García I; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Borkhardt A; Departamento de Cirugía, Universidad de Salamanca, Salamanca, Spain.
Cancer Res ; 77(16): 4365-4377, 2017 08 15.
Article in En | MEDLINE | ID: mdl-28630052
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Oncogene Proteins, Fusion / Core Binding Factor Alpha 2 Subunit / Histone Demethylases Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Res Year: 2017 Document type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Oncogene Proteins, Fusion / Core Binding Factor Alpha 2 Subunit / Histone Demethylases Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Res Year: 2017 Document type: Article Affiliation country: Spain